Cargando…
Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial
HIV endpoint–driven clinical trials provide oral pre-exposure prophylaxis (PrEP) as HIV prevention standard of care. We evaluated quantifiable plasma tenofovir among South African women who used oral PrEP during the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial. METHODS: ECHO, a r...
Autores principales: | Beesham, Ivana, Mansoor, Leila E., Joseph Davey, Dvora L., Palanee-Phillips, Thesla, Smit, Jenni, Ahmed, Khatija, Selepe, Pearl, Louw, Cheryl, Singata-Madliki, Mandisa, Kotze, Philip, Heffron, Renee, Parikh, Urvi M., Wiesner, Lubbe, Rees, Helen, Baeten, Jared M., Beksinska, Mags |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377486/ https://www.ncbi.nlm.nih.gov/pubmed/35972853 http://dx.doi.org/10.1097/QAI.0000000000003023 |
Ejemplares similares
-
High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study
por: Beesham, Ivana, et al.
Publicado: (2022) -
Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
por: Beesham, Ivana, et al.
Publicado: (2023) -
Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial
por: Beesham, Ivana, et al.
Publicado: (2020) -
Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial
por: Beesham, Ivana, et al.
Publicado: (2020) -
Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial
por: Beksinska, Mags, et al.
Publicado: (2021)